News 26 oct 2022 Chinese vaccine manufacturer CanSino Biologics sets up shop in Geneva to launch its inhaled Covid vaccine This first inhaled Covid vaccine against was approved by Chinese authorities a month ago. This technology has the potential to protect against ot...
News 26 mai 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
News 04 oct 2023 Atinary Technologies raises USD 5 million to accelerate material and molecular innovation Vaud-based machine learning specialist Atinary Technologies has raised USD 5 million, propelling the start-up towards a new era of material and m...
News 14 aoû 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
Actualités 03 nov 2023 L’EPFL et Novochizol collaborent à la conception d’immunothérapies plus efficaces Une collaboration entre le Laboratoire de Biomatériaux pour l’Immuno-ingénierie de l’EPFL et Novochizol vise à révolutionner le traitement du can...
News 03 aoû 2023 Worg secures financing of 130 million Swiss francs The Chinese biopharmaceutical firm Worg Pharma, whose European headquarters are located in the Basel Area, has secured gross proceeds equivalent ...
Actualités 04 oct 2023 Atinary Technologies lève USD 5 millions pour accélérer l’innovation matérielle et moléculaire Le spécialiste vaudois de l’apprentissage automatique, Atinary Technologies, a levé USD 5 millions, propulsant la start-up vers une nouvelle ère ...
News 10 juil 2023 BioLingus seeks Nasdaq listing BioLingus has filed an application for an IPO on the Nasdaq stock exchange in New York. The pharmaceutical firm is seeking to raise around 47 mil...
Aktuell 03 aoû 2023 Worg erhält Finanzierung von 130 Millionen Franken Das biopharmazeutische chinesische Unternehmen Worg Pharma mit Europasitz in der Basel Area hat in einer Finanzierungsrunde der Serie C umgerechn...
Actualités 14 aoû 2023 L’écosystème florissant de Berne pour l’innovation en sciences de la vie Au cœur de la Suisse occidentale, le canton de Berne s'est imposé comme une destination de choix pour les entreprises du secteur des sciences de ...
News 08 mai 2023 RetinAI partners with Boehringer Ingelheim to improve retinal disease treatment Bern-based RetinAI Medical, a pioneer in clinical and imaging data management software and advanced analytics using AI for ophthalmology, has joi...
Actualités 04 juil 2023 Les Grands Titres de Suisse occidentale (Avril-Juin 2023) De l’exploration spatiale aux percées médicales en passant par des avancées dans les domaines de la formation et des technologies, découvrez les ...
News 16 nov 2022 Valais-based electrochemistry specialist RedElec wins the Swiss Startcup Challenge Redelec has won the Swiss Startcup Challenge organized by Nespresso Switzerland and B Lab Switzerland. This prize rewards companies that prioriti...
Aktuell 10 juil 2023 BioLingus will an die Nasdaq BioLingus hat einen Antrag auf Börsengang an der Nasdaq in New York gestellt. Das Pharmaunternehmen will rund 47 Millionen Dollar einnehmen. BioL...
Report 27 aoû 2021 スイスの循環型経済 現在の直線型経済モデルは「take-make-waste」の原則に支配されています。その結果、生態系や天然資源への圧力が増しています。直線型経済モデルは、資源不足や資源の浪費を生み、最後には気候変動や生物多様性損失などの環境危機が生じます。人類は地球の限界(プラネタリー・バウンダリー)を超...
News 31 mai 2022 RetinAI enters a multi-year software license agreement with Novartis Building on their existing relationship, Bern-based RetinAI and pharma giant Novartis have entered a long-term collaboration with a multi-year so...